# EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

> **NCT06375954** · NA · NOT_YET_RECRUITING · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 96 (estimated)

## Conditions studied

- Malignant Biliary Obstruction
- Pancreatic Cancer
- Biliary Tract Neoplasms

## Interventions

- **PROCEDURE:** Endoscopic biliary drainage
- **DEVICE:** Self-expandable metallic stent (SEMS)
- **DEVICE:** Lumen-apposing metal stent (LAMS) and double-pigtail plastic stent (DPPS)

## Key facts

- **NCT ID:** NCT06375954
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375954, "EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06375954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*